Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C3AR1 |
| Upstream (Parents) |
|---|
| (<<) MS4A4A → C3AR1 |
| (<<) LY96 → C3AR1 |
| (<<) FCGR1C///FCGR1A → C3AR1 |
| (<<) CD86 → C3AR1 |
| Downstream (Children) |
|---|
| C3AR1 → LY86 (>>) |
| C3AR1 → DSE (>>) |
| C3AR1 → TM6SF1 (>>) |
| C3AR1 → AKR1B1 (>>) |
| C3AR1 → P2RX7 (>>) |
| C3AR1 → TLR7 (>>) |
| C3AR1 → MS4A4A (>>) |
| C3AR1 → LAIR1 (>>) |
| C3AR1 → SLC15A3 (>>) |
| C3AR1 → CD74 (>>) |
| C3AR1 → CFD (>>) |
| C3AR1 → KCTD12 (>>) |
| C3AR1 → FCGR1C///FCGR1A (>>) |
| C3AR1 → ADORA3 (>>) |
| C3AR1 → FCGR1B (>>) |
| C3AR1 → CD86 (>>) |
| C3AR1 → FPR3 (>>) |
